Skip to main content
Veterinary Medicines

Linco-Spectin 50 mg/100 mg/ml - Injektionslösung für Tiere

Authorised
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate

Product identification

Medicine name:
Linco-Spectin 50 mg/100 mg/ml - Injektionslösung für Tiere
Active substance:
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate
Target species:
  • Cattle (pre-ruminant)
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride monohydrate
    56.70
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin sulfate tetrahydrate
    151.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (pre-ruminant)
      • Meat and offal
        21
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Osterreich GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00042
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 17/12/2020

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 10/02/2015

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 10/02/2015
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."